Format

Send to

Choose Destination
J Exp Med. 2008 Dec 22;205(13):3091-103. doi: 10.1084/jem.20081163. Epub 2008 Dec 15.

Prostaglandin E2 regulates B cell proliferation through a candidate tumor suppressor, Ptger4.

Author information

1
CEA, DSV, Institut de Radiobiologie Cellulaire et Moléculaire, Laboratoire d'Exploration Fonctionnelle des Génomes, Evry, France.

Abstract

B cell receptor (BCR) signaling contributes to the pathogenesis of B cell malignancies, and most B cell lymphomas depend on BCR signals for survival. Identification of genes that restrain BCR-mediated proliferation is therefore an important goal toward improving the therapy of B cell lymphoma. Here, we identify Ptger4 as a negative feedback regulator of proliferation in response to BCR signals and show that its encoded EP4 receptor is a principal molecule conveying the growth-suppressive effect of prostaglandin E2 (PGE2). Stable knockdown of Ptger4 in B cell lymphoma markedly accelerated tumor spread in mice, whereas Ptger4 overexpression yielded significant protection. Mechanistically, we show that the intrinsic activity of Ptger4 and PGE2-EP4 signaling target a similar set of activating genes, and find Ptger4 to be significantly down-regulated in human B cell lymphoma. We postulate that Ptger4 functions in B cells as a candidate tumor suppressor whose activity is regulated by PGE2 in the microenvironment. These findings suggest that targeting EP4 receptor for prostaglandin may present a novel strategy for treatment of B cell malignancies.

PMID:
19075289
PMCID:
PMC2605229
DOI:
10.1084/jem.20081163
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center